Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1147-2014

Drug recall · March 12, 2014

Bupivacaine HCl Inj. USP recall

Why: Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1162-02

Lots / codes

Lot 25-097-DK; Exp 01/01/2015

Quantity
115,500 Vials
Company
Hospira Inc., Lake Forest, IL
Distribution
Nationwide
Initiated
February 10, 2014 · Voluntary: Firm initiated
Classified
March 5, 2014
Reported
March 12, 2014
Ended
February 1, 2017
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Bupivacaine

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.